Structure of ACET, (S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione.
<a href="//commons.wikimedia.org/wiki/User_talk:%D0%86%D0%B3%D0%BE%D1%80_%D0%9F%D1%94%D1%82%D0%BA%D0%BE%D0%B2" title="User talk:Ігор Пєтков">Ігор Пєтков</a>
<p>Own work based on:
</p>
<ul><li><cite style="font-style:normal">Dargan, Sheila L.; Clarke, Vernon R.J.; Alushin, Gregory M.; Sherwood, John L.; Nisticò, Robert; Bortolotto, Zuner A.; Ogden, Ann M.; Bleakman, David; Doherty, Andrew J. (2009). "<a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637447/pdf/nihms-87062.pdf">ACET is a highly potent and specific kainate receptor antagonist: Characterisation and effects on hippocampal mossy fibre function</a>". <i>Neuropharmacology</i> <b>56</b> (1): 121–130. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" class="extiw" title="w:Digital object identifier">DOI</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016/j.neuropharm.2008.08.016">10.1016/j.neuropharm.2008.08.016</a>.</cite></li></ul>